We are live on ! Find out more

Micro Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
ECOR icon
201
electroCore
ECOR
$52M
$52M $6.27 2.03%
INMB icon
202
INmune Bio
INMB
$51.8M
$51.8M $1.95 1.02%
BYSI icon
203
BeyondSpring
BYSI
$51.4M
$51.4M $1.25 0%
MCRB icon
204
Seres Therapeutics
MCRB
$51M
$51M $5.27 0.38%
POCI icon
205
Precision Optics
POCI
$49.7M
$49.7M $4.54 0.22%
EXOZ
206
eXoZymes Inc
EXOZ
$49.5M
$49.5M $5.33 0%
SRTS icon
207
Sensus Healthcare
SRTS
$49.4M
$49.4M $3 1.32%
MREO
208
Mereo BioPharma
MREO
$49.4M
$49.4M $0.3092 1.11%
TIL icon
209
Instil Bio
TIL
$49.2M
$49.2M $7.25 0%
ATYR
210
aTyr Pharma
ATYR
$48M
$48M $0.4899 0.82%
FLNA
211
Filana Therapeutics
FLNA
$47.8M
$47.8M $0.9900 1.98%
IBO
212
Impact BioMedical
IBO
$47.5M
$47.5M $0.4410 0%
MGX icon
213
Metagenomi Therapeutics
MGX
$47.4M
$47.4M $1.26 3.28%
DWTX
214
Dogwood Therapeutics
DWTX
$46.7M
$46.7M $1.39 0.71%
PRPO icon
215
Precipio
PRPO
$43.8M
$43.8M $24.49 3.33%
PDSB icon
216
PDS Biotechnology
PDSB
$42.5M
$42.5M $0.7608 0.11%
ELOX
217
Eloxx Pharmaceuticals
ELOX
$42.3M
$42.3M $12.30 2.5%
PETS icon
218
PetMed Express
PETS
$42.1M
$42.1M $1.97 1.01%
ELUT icon
219
Elutia
ELUT
$42M
$42M $0.9500 0%
HYPD
220
Hyperion DeFi Inc
HYPD
$41.4M
$41.4M $2.73 1.09%
QTI
221
QT Imaging Holdings
QTI
$41.3M
$41.3M $3 2.91%
APLM icon
222
Apollomics
APLM
$40.4M
$40.4M $18.38 1.76%
SCYX icon
223
SCYNEXIS
SCYX
$40M
$40M $4.03 0.49%
NEPH icon
224
Nephros
NEPH
$40M
$40M $3.68 2.51%
PAVM icon
225
PAVmed
PAVM
$39.7M
$39.7M $5.54 0%

Micro Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 492 micro cap Healthcare stocks — companies in the Healthcare sector with a market cap under $250M — worth a combined $31.4B.

The largest by market cap are Profound Medical (PROF) at $249M, Entrada Therapeutics (TRDA) at $249M and Fulcrum Therapeutics (FULC) at $246M.

Among institutional investors, Atrium Therapeutics (RNA) drew the most net new fund positions in Q1 2026: 162 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.